Global Health
Today, BD is scaling up our response to disease pandemics in the developing world by focusing efforts in four key areas: increasing access to critically needed technologies, building healthcare capacity, investing in new technologies, and supporting volunteerism and philanthropy.
Collaborating across the private and public sectors, BD programs focus on creating sustainable approaches to HIV/AIDS, tuberculosis (TB), and malaria.
* Does not constitute medical or legal advice, including with respect to regulatory practices or industry standards, specifically 21 CFR Part 58 Good Laboratory Practice for Nonclinical Laboratory Studies.
BD Biosciences provides flow cytometers, reagents, tools and a wide range of services to support the work of researchers and clinicians who understand disease and improve care.